Albumin infusion (Albuminar, Plasbumin) may support people with advanced liver disease by expanding blood volume, maintaining circulation, and improving blood flow to the kidneys. It can also reduce complications after large-volume paracentesis and is an important component of hepatorenal syndrome treatment. The extent of these benefits varies from person to person, depending on liver condition, kidney function, and how the body responds to therapy. Albumin infusion is not a stand-alone treatment for liver disease. It works best as part of a broader care plan that includes a sodium-restricted diet when ascites is present, medications as directed, and regular monitoring.
As with any treatment, albumin infusion may cause side effects. These include fluid overload, high blood pressure, nausea, fever, and infusion-related reactions. Your healthcare team monitors you during and after treatment and adjusts your care plan as needed.